Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04815187 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 18, 2025 (before its estimated September 3, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruitingv4 Show 4 more changesShow less
    • Enrollment target: estimated 40 to confirmed 39
    • Primary completion date: Jun 30, 2025 to Sep 3, 2025
    • Site details revised at 2 of 2 sites
    • Eligibility criteria expanded, about 2 words
  2. Primary completion date: Apr 2022 to Jun 30, 2025
    • Study completion date: Apr 2022 to Dec 31, 2025
    • Start date changed from estimate of Mar 2021 to Jun 7, 2021
    • Site contacts updated at 2 of 2 sites
    v3
  3. Study sites revised (2)v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate a previously FDA-approved medication that is known to help with allergy symptoms to see if it can decrease symptoms in patients with Meniere's Disease.
Trial Details
NCT Number NCT04815187
Lead Sponsor House Ear Institute
Collaborators: Cures Within Reach
Conditions
(from sponsor)		 Meniere Disease, Allergic Rhinitis, Vertigo
Related terms Meniere Disease, Rhinitis, Allergic, Vertigo
Enrollment 39 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov